Funding for Ixekizumab
Ms Faulkner made this Official Information request to Pharmaceutical Management Agency
This request has an unknown status. We're waiting for Ms Faulkner to read a recent response and update the status.
From: Ms Faulkner
Dear Pharmaceutical Management Agency,
I am requesting information about the funding of Ixekizumab (brand name Taltz).
Specifically, I would like to know if:
a) This medication is currently being considered for funding, has been considered for funding in the past, or if there is any indication it will be considered in the near future?
b) If the medication is being considered for funding, I would like to know which autoimmune conditions it is being considered as a treatment option for.
Yours faithfully,
Ms Faulkner
From: Web Enquiry
Pharmaceutical Management Agency
2022 23 220 2023 03 13 Response Letter Information on the funding of ixekizumab Taltz.pdf
125K
Download
View as HTML
Kia ora Ms Faulkner,
Please find a response to your request attached to this email.
Kind regards,
Gendi McFadyen| Government Services Advisor
Te Pātaka Whaioranga | Pharmac
PO Box 10-254, Wellington 6140 | Level 9, 40 Mercer Street, Wellington 6011
P: 0800 660 050 | www.pharmac.govt.nz
show quoted sections
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence
Offensive? Unsuitable?
Requests for personal information and vexatious requests are not considered valid requests for Official Information (read more).
If you believe this request is not suitable, you can report it for attention by the site administrators
Report this request